WHWK
Whitehawk Therapeutics Inc- Healthcare
- Biotechnology
- $234M market cap
Forecast run · Sep 14, 2026Upside rank 502 of 3,136
Model Signal
ForecastQ Daily Probabilities
55.6%
52.2%
33.6%
Analyst Consensus
RecommendationNot rated
Last price$4.11
Price target$8.00
Implied move+94.6%
ForecastQ Portfolios
WHWK is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.